http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Nucleoside analogs: cellular pharmacology, mechanisms of action, and strategies for combination therapy / William Plunkett and Varsha Gandhi -- Induction of apoptosis by nucleoside analogs / Peng Huang and Susan Wright -- Pharmacokinetics of purine nucleoside analogs / Jan Lilemark and Gunnar Juliusson -- Clinical development of 2'-deoxycoformycin / Bruce D. Cheson and Michael R. Grever -- Clinical development of fludarabine / Axel-R. Hanauske and Daniel D. Von Hoff.
Development of 2-chlorodeoxyadenosine (2-CdA) as a chemotherapeutic and immunosuppressive drug / Ernest Beutler ... [et al.] -- Defining the optimal dose schedule of purine analogs and assessment of response / Jorge E. Cortes and Susan M. O'Brien -- Clinical trials of the purine analogs in chronic lymphocytic leukemia / Michael J. Keating -- Treatment of hairy cell leukemia with nucleoside analogs / Alan Saven and Lawrence D. Piro -- Clinical trials with nucleoside analogs in lymphomas / Wolfgang Hiddemann and Christiane Pott-Hoeck.
Clinical trials with nucleoside in other hematologic malignancies / Jorge E. Cortes ... [et al.] -- Nucleoside analogs in radiosensitizing agents / Vincent Grégoire and Walter N. Hittelman -- 2-Chlorodeoxyadenosine in nonmalignant disorders / Ernest Beutler ... [et al.] -- Fludarabine in nonmalignant disorders / Ioannis O. Tassiulas ... [et al.] -- Toxicities associated with purine analog therapy / Bruce E. Cheson.
edited by Bruce D. Cheson, Michael J. Keating, William Plunkett.
Includes bibliographical references and index.